Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05529875Withdrawn
Randomised, single-blind trial of propofol injection (veterinary) and sevoflurane in anal fistula (2 arms). Primary endpoint: Quality of Recovery-40 at 48 hours. Planned start Oct 2022; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05529875.